METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE was reported 59278 times

METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 40 0.4167
1 PULMONARY VASCULITIS 116 0.2156
2 NEUROLOGIC NEGLECT SYNDROME 114 0.2050
3 PROLONGED EXPIRATION 40 0.1527
4 CAPILLARITIS 41 0.1486
5 HYPOCHOLESTEROLAEMIA 52 0.1473
6 TOTAL LUNG CAPACITY ABNORMAL 57 0.1465
7 LACTIC ACIDOSIS 4696 0.1449
8 HUMAN RHINOVIRUS TEST POSITIVE 54 0.1448
9 CAROTID ARTERY THROMBOSIS 120 0.1413
10 ALVEOLAR OSTEITIS 54 0.1277
11 URINARY TRACT DISCOMFORT 56 0.1215
12 CEREBRAL HYPOPERFUSION 55 0.1180
13 SPIROMETRY ABNORMAL 67 0.1120
14 VIRAL TEST POSITIVE 39 0.1074
15 EUGLYCAEMIC DIABETIC KETOACIDOSIS 431 0.1043
16 ADJUSTMENT DISORDER 120 0.0923
17 PNEUMONIA HAEMOPHILUS 43 0.0885
18 MITE ALLERGY 56 0.0855
19 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 55 0.0782
20 DIABETIC METABOLIC DECOMPENSATION 103 0.0742
21 HYPOGLYCAEMIC COMA 206 0.0714
22 MYCOTIC ALLERGY 58 0.0678
23 NEURITIS 103 0.0667
24 HYPERLACTACIDAEMIA 177 0.0659
25 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 47 0.0641
26 FACET JOINT SYNDROME 208 0.0638
27 CONTINUOUS HAEMODIAFILTRATION 61 0.0623
28 ANIMAL SCRATCH 57 0.0586
29 DUST ALLERGY 57 0.0581
30 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 53 0.0572
31 KETOSIS 54 0.0498
32 PERIPHERAL VENOUS DISEASE 203 0.0497
33 PERSONALITY DISORDER 128 0.0488
34 CONJUNCTIVITIS ALLERGIC 71 0.0479
35 METABOLIC ACIDOSIS 1457 0.0455
36 ONYCHOMADESIS 186 0.0443
37 ONYCHOMYCOSIS 189 0.0430
38 DISTRIBUTIVE SHOCK 97 0.0428
39 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 85 0.0416
40 VITAMIN B12 DEFICIENCY 167 0.0412
41 RESPIRATORY SYMPTOM 113 0.0397
42 INFUSION SITE DISCHARGE 64 0.0365
43 HYPOGLYCAEMIA 1704 0.0351
44 BLEPHAROSPASM 208 0.0330
45 DIABETES MELLITUS INADEQUATE CONTROL 561 0.0317
46 RHEUMATIC FEVER 140 0.0314
47 BREAST CANCER STAGE III 196 0.0302
48 C-REACTIVE PROTEIN ABNORMAL 194 0.0302
49 EXPOSURE VIA INGESTION 75 0.0297
50 VASOPLEGIA SYNDROME 47 0.0286
51 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 204 0.0284
52 TUNNEL VISION 53 0.0283
53 URINE KETONE BODY PRESENT 43 0.0272
54 BLOOD LACTIC ACID INCREASED 141 0.0267
55 KETOACIDOSIS 200 0.0267
56 HAEMODIALYSIS 224 0.0266
57 DUODENAL ULCER PERFORATION 198 0.0266
58 SINUS PAIN 62 0.0266
59 DISLOCATION OF VERTEBRA 60 0.0263
60 FINGER DEFORMITY 126 0.0260
61 DIABETIC NEPHROPATHY 56 0.0254
62 HYPOGLYCAEMIA NEONATAL 41 0.0253
63 FOLLICULITIS 259 0.0247
64 INFUSION SITE HAEMORRHAGE 80 0.0243
65 NORMOCHROMIC NORMOCYTIC ANAEMIA 73 0.0243
66 WOUND COMPLICATION 83 0.0242
67 RALES 140 0.0241
68 FORCED EXPIRATORY VOLUME DECREASED 68 0.0240
69 HYPERKALAEMIA 838 0.0239
70 MUSCLE INJURY 197 0.0238
71 BURSITIS 284 0.0234
72 DIABETIC KETOACIDOSIS 559 0.0232
73 POLYMYALGIA RHEUMATICA 73 0.0230
74 SHOCK 527 0.0229
75 EYELID PAIN 46 0.0226
76 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 52 0.0225
77 ANURIA 194 0.0225
78 NAIL DISORDER 196 0.0224
79 ACUTE KIDNEY INJURY 3416 0.0223
80 TONGUE BITING 46 0.0223
81 EAR CONGESTION 60 0.0221
82 DEEP VEIN THROMBOSIS POSTOPERATIVE 44 0.0220
83 NEUROLOGICAL SYMPTOM 125 0.0218
84 PULMONARY ALVEOLAR HAEMORRHAGE 120 0.0214
85 HYPOTHERMIA 214 0.0211
86 INFUSION SITE REACTION 63 0.0211
87 DIABETIC NEUROPATHY 104 0.0210
88 ALANINE AMINOTRANSFERASE ABNORMAL 44 0.0208
89 VITAMIN B12 DECREASED 60 0.0208
90 MEDICATION RESIDUE PRESENT 99 0.0207
91 HYPERCHOLESTEROLAEMIA 196 0.0203
92 GLYCOSYLATED HAEMOGLOBIN INCREASED 509 0.0201
93 OSTEOLYSIS 41 0.0200
94 DIABETIC RETINOPATHY 68 0.0200
95 ARTERIOSCLEROSIS CORONARY ARTERY 132 0.0199
96 LIVE BIRTH 166 0.0198
97 INFUSION SITE INFECTION 46 0.0198
98 LIP DRY 179 0.0197
99 BACK INJURY 214 0.0197
100 HEMIPLEGIA 162 0.0195
101 PEMPHIGUS 243 0.0194
102 JOINT RANGE OF MOTION DECREASED 260 0.0194
103 SYNOVITIS 349 0.0193
104 HYPOVOLAEMIA 113 0.0193
105 HELICOBACTER INFECTION 196 0.0191
106 HAND DEFORMITY 250 0.0190
107 OBSTRUCTIVE AIRWAYS DISORDER 212 0.0190
108 OBESITY 303 0.0190
109 INFUSION SITE BRUISING 41 0.0190
110 BLADDER PAIN 59 0.0186
111 ACIDOSIS 140 0.0183
112 PARANASAL SINUS DISCOMFORT 69 0.0182
113 HYPERGLYCAEMIA 663 0.0182
114 TYPE 2 DIABETES MELLITUS 592 0.0176
115 TOXIC ENCEPHALOPATHY 89 0.0176
116 DRUG LEVEL ABOVE THERAPEUTIC 80 0.0174
117 DRUG LEVEL INCREASED 287 0.0173
118 POTENTIATING DRUG INTERACTION 58 0.0173
119 PRODUCT ODOUR ABNORMAL 181 0.0173
120 WOUND INFECTION 189 0.0172
121 PEMPHIGOID 129 0.0171
122 PULSELESS ELECTRICAL ACTIVITY 71 0.0170
123 GANGRENE 102 0.0169
124 SENSORY LOSS 136 0.0169
125 BLOOD GLUCOSE FLUCTUATION 184 0.0168
126 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 285 0.0168
127 HYPOMAGNESAEMIA 233 0.0167
128 BONE EROSION 59 0.0167
129 FULL BLOOD COUNT ABNORMAL 176 0.0166
130 PANCREATIC CARCINOMA METASTATIC 47 0.0165
131 PRODUCT RESIDUE PRESENT 88 0.0163
132 CONGENITAL ANOMALY 126 0.0163
133 PRODUCT ADMINISTRATION INTERRUPTED 126 0.0160
134 NORMAL NEWBORN 87 0.0160
135 GRIP STRENGTH DECREASED 140 0.0159
136 KERATITIS 48 0.0158
137 PERICARDITIS 265 0.0158
138 SEASONAL ALLERGY 222 0.0157
139 TASTE DISORDER 317 0.0156
140 AFFECT LABILITY 150 0.0156
141 EXPOSURE DURING PREGNANCY 963 0.0155
142 WOUND SECRETION 59 0.0151
143 HYPOVOLAEMIC SHOCK 72 0.0150
144 HEPATIC FIBROSIS 51 0.0148
145 PRODUCT LABEL CONFUSION 86 0.0147
146 WRONG PATIENT RECEIVED PRODUCT 43 0.0147
147 INFUSION SITE PRURITUS 46 0.0146
148 COMA SCALE ABNORMAL 42 0.0145
149 SKIN INJURY 48 0.0145
150 BLOOD PRESSURE SYSTOLIC INCREASED 282 0.0144
151 BLOOD SODIUM INCREASED 39 0.0144
152 BRONCHIECTASIS 97 0.0144
153 HAEMOGLOBIN INCREASED 65 0.0142
154 INFUSION SITE PAIN 183 0.0142
155 HAEMODYNAMIC INSTABILITY 106 0.0139
156 PANCREATITIS ACUTE 310 0.0138
157 NASAL POLYPS 66 0.0134
158 DEPRESSIVE SYMPTOM 47 0.0133
159 MOTOR DYSFUNCTION 135 0.0132
160 INFUSION SITE SWELLING 83 0.0132
161 CUTANEOUS VASCULITIS 48 0.0131
162 C-REACTIVE PROTEIN INCREASED 472 0.0130
163 POLYURIA 106 0.0129
164 WOUND 360 0.0129
165 INFUSION SITE ERYTHEMA 108 0.0128
166 HEPATIC STEATOSIS 237 0.0127
167 IRRITABLE BOWEL SYNDROME 272 0.0127
168 DIABETES MELLITUS 951 0.0125
169 CONTRAINDICATED PRODUCT ADMINISTERED 376 0.0124
170 MOUTH HAEMORRHAGE 91 0.0124
171 SINUS DISORDER 245 0.0124
172 SKIN HAEMORRHAGE 183 0.0123
173 BLOOD GLUCOSE ABNORMAL 228 0.0123
174 MULTIPLE ORGAN DYSFUNCTION SYNDROME 346 0.0122
175 HEPATIC CYTOLYSIS 155 0.0121
176 APPETITE DISORDER 80 0.0121
177 BLOOD PRESSURE DIASTOLIC DECREASED 88 0.0119
178 POLYDIPSIA 47 0.0119
179 OPTIC ISCHAEMIC NEUROPATHY 46 0.0119
180 ARTERIOSCLEROSIS 111 0.0118
181 BLOOD IRON DECREASED 139 0.0117
182 GLOSSODYNIA 262 0.0117
183 VASCULITIS 136 0.0117
184 RENAL TUBULAR NECROSIS 114 0.0116
185 RED CELL DISTRIBUTION WIDTH INCREASED 48 0.0115
186 RENAL FAILURE ACUTE 490 0.0115
187 HEMIPARESIS 194 0.0114
188 FIBROMYALGIA 278 0.0114
189 COELIAC DISEASE 112 0.0114
190 BODY TEMPERATURE DECREASED 112 0.0114
191 HYPERVOLAEMIA 56 0.0113
192 AZOTAEMIA 45 0.0113
193 PULMONARY FIBROSIS 214 0.0111
194 OSTEOARTHRITIS 472 0.0111
195 MULTIPLE ALLERGIES 87 0.0111
196 RESPIRATION ABNORMAL 76 0.0110
197 CARDIAC DYSFUNCTION 41 0.0110
198 MUSCLE SPASTICITY 135 0.0110
199 LIVER INJURY 269 0.0109
200 OLIGURIA 68 0.0109
201 ARTERIAL OCCLUSIVE DISEASE 86 0.0109
202 DRUG-INDUCED LIVER INJURY 343 0.0109
203 HYPERNATRAEMIA 54 0.0108
204 MYOPATHY 93 0.0108
205 GLOMERULAR FILTRATION RATE DECREASED 132 0.0107
206 DYSLIPIDAEMIA 54 0.0106
207 RENAL CYST 84 0.0106
208 INFLAMMATORY MARKER INCREASED 52 0.0105
209 BLINDNESS TRANSIENT 77 0.0104
210 HYPOTHYROIDISM 333 0.0104
211 PSORIATIC ARTHROPATHY 418 0.0103
212 TUBULOINTERSTITIAL NEPHRITIS 192 0.0102
213 ELECTROLYTE IMBALANCE 119 0.0102
214 INTENTIONAL OVERDOSE 657 0.0102
215 LUNG DISORDER 500 0.0102
216 COORDINATION ABNORMAL 142 0.0102
217 GLUCOSE TOLERANCE IMPAIRED 60 0.0101
218 BLOOD PRESSURE SYSTOLIC DECREASED 46 0.0101
219 WHEEZING 596 0.0100
220 ADVERSE REACTION 133 0.0100
221 BLOOD CHOLESTEROL INCREASED 467 0.0100
222 LOWER RESPIRATORY TRACT INFECTION 454 0.0100
223 RESPIRATORY TRACT CONGESTION 157 0.0099
224 FLANK PAIN 92 0.0098
225 PYELONEPHRITIS 85 0.0098
226 EXOSTOSIS 89 0.0097
227 BLOOD GLUCOSE INCREASED 1829 0.0097
228 TACHYPNOEA 131 0.0096
229 LEFT VENTRICULAR HYPERTROPHY 41 0.0096
230 COMPLETED SUICIDE 796 0.0095
231 GAIT INABILITY 319 0.0095
232 PRODUCT SOLUBILITY ABNORMAL 48 0.0095
233 OVERWEIGHT 51 0.0095
234 SOPOR 125 0.0094
235 UROSEPSIS 87 0.0094
236 DYSARTHRIA 354 0.0094
237 EATING DISORDER 199 0.0093
238 PRODUCTIVE COUGH 446 0.0093
239 TROPONIN INCREASED 71 0.0093
240 HYPOKINESIA 135 0.0093
241 BENIGN PROSTATIC HYPERPLASIA 48 0.0093
242 NEPHROGENIC ANAEMIA 43 0.0093
243 HYPERURICAEMIA 38 0.0092
244 DYSPNOEA EXERTIONAL 347 0.0092
245 HEPATIC CIRRHOSIS 173 0.0092
246 ESCHERICHIA URINARY TRACT INFECTION 39 0.0092
247 CORONARY ARTERY STENOSIS 46 0.0091
248 BLOOD CHOLESTEROL ABNORMAL 42 0.0091
249 NIGHT SWEATS 292 0.0091
250 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 434 0.0090
251 ATRIOVENTRICULAR BLOCK FIRST DEGREE 39 0.0090
252 LIVER FUNCTION TEST INCREASED 193 0.0090
253 TOXICITY TO VARIOUS AGENTS 1515 0.0090
254 BLOOD GLUCOSE DECREASED 428 0.0089
255 LIMB INJURY 242 0.0089
256 IRON DEFICIENCY 40 0.0089
257 RED BLOOD CELL SEDIMENTATION RATE INCREASED 98 0.0088
258 GASTROENTERITIS 129 0.0088
259 ATRIOVENTRICULAR BLOCK COMPLETE 59 0.0088
260 ACUTE CORONARY SYNDROME 73 0.0088
261 BLOOD MAGNESIUM DECREASED 76 0.0088
262 METABOLIC DISORDER 51 0.0088
263 EPILEPSY 268 0.0088
264 SKIN LACERATION 95 0.0087
265 BREATH SOUNDS ABNORMAL 43 0.0087
266 HEPATITIS 222 0.0087
267 ANAL INCONTINENCE 78 0.0087
268 HYPOCALCAEMIA 163 0.0086
269 IMPAIRED HEALING 282 0.0086
270 MITRAL VALVE INCOMPETENCE 97 0.0086
271 NOCTURIA 104 0.0086
272 PERIPHERAL VASCULAR DISORDER 44 0.0085
273 LEFT VENTRICULAR DYSFUNCTION 57 0.0085
274 CARDIOGENIC SHOCK 122 0.0085
275 HAEMOLYTIC ANAEMIA 76 0.0085
276 CHOLECYSTITIS 101 0.0085
277 FOREIGN BODY SENSATION IN EYES 54 0.0085
278 UPPER RESPIRATORY TRACT INFECTION 391 0.0085
279 IMPAIRED GASTRIC EMPTYING 115 0.0084
280 MYOSITIS 75 0.0084
281 SCIATICA 133 0.0083
282 CHOKING SENSATION 46 0.0083
283 PRE-EXISTING CONDITION IMPROVED 52 0.0083
284 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 42 0.0083
285 SLEEP APNOEA SYNDROME 157 0.0082
286 GASTROOESOPHAGEAL REFLUX DISEASE 656 0.0081
287 SINUS CONGESTION 110 0.0081
288 INSURANCE ISSUE 124 0.0081
289 BLISTER 452 0.0080
290 COVID-19 PNEUMONIA 95 0.0080
291 PARKINSONISM 78 0.0080
292 RESPIRATORY RATE INCREASED 71 0.0080
293 APHASIA 241 0.0080
294 ANGINA PECTORIS 228 0.0079
295 SINUS TACHYCARDIA 112 0.0079
296 EYE PAIN 444 0.0079
297 HYPERTRIGLYCERIDAEMIA 46 0.0078
298 LARGE INTESTINE POLYP 54 0.0078
299 BRADYKINESIA 46 0.0078
300 ACUTE MYOCARDIAL INFARCTION 229 0.0078
301 HYPOPHAGIA 196 0.0077
302 GASTROINTESTINAL DISORDER 685 0.0076
303 BLOOD PRESSURE INADEQUATELY CONTROLLED 46 0.0076
304 BLOOD POTASSIUM INCREASED 124 0.0076
305 DERMATITIS CONTACT 87 0.0076
306 HYPOKALAEMIA 350 0.0076
307 ENCEPHALOPATHY 186 0.0076
308 ALTERED STATE OF CONSCIOUSNESS 164 0.0076
309 BLOOD CREATININE INCREASED 494 0.0076
310 PRODUCT DOSE OMISSION IN ERROR 214 0.0075
311 JOINT INJURY 161 0.0075
312 MICTURITION URGENCY 86 0.0075
313 RENAL FAILURE 997 0.0075
314 HYPOTENSION 1505 0.0075
315 NEPHROPATHY 70 0.0075
316 SYSTEMIC LUPUS ERYTHEMATOSUS 266 0.0075
317 BLOOD URIC ACID INCREASED 43 0.0074
318 LIPASE INCREASED 57 0.0074
319 URINE OUTPUT DECREASED 65 0.0074
320 FRUSTRATION TOLERANCE DECREASED 60 0.0074
321 MYOCARDITIS 85 0.0074
322 SPUTUM DISCOLOURED 70 0.0074
323 EAR PAIN 143 0.0073
324 MATERNAL EXPOSURE DURING PREGNANCY 654 0.0073
325 CONFUSIONAL STATE 1185 0.0073
326 DIZZINESS POSTURAL 71 0.0073
327 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 74 0.0072
328 CHOLELITHIASIS 236 0.0072
329 RENAL IMPAIRMENT 604 0.0072
330 ASTHMA 809 0.0072
331 INFLAMMATION 368 0.0071
332 SHOCK HAEMORRHAGIC 58 0.0071
333 CATARACT OPERATION 42 0.0071
334 CHOLECYSTITIS ACUTE 40 0.0071
335 ARTHROPATHY 392 0.0070
336 DIARRHOEA 4541 0.0070
337 BLOOD URINE PRESENT 133 0.0070
338 ATRIOVENTRICULAR BLOCK 54 0.0070
339 MUSCULAR WEAKNESS 793 0.0070
340 CYSTITIS 222 0.0070
341 CONCOMITANT DISEASE AGGRAVATED 43 0.0070
342 PANCREATITIS 368 0.0070
343 HYPERLIPIDAEMIA 83 0.0069
344 MYOCARDIAL ISCHAEMIA 79 0.0069
345 DRUG INTERACTION 1101 0.0069
346 FAECALOMA 38 0.0069
347 DEHYDRATION 925 0.0069
348 THERAPEUTIC PRODUCT EFFECT DECREASED 310 0.0069
349 HYPOPHOSPHATAEMIA 51 0.0069
350 RHABDOMYOLYSIS 287 0.0069
351 CAESAREAN SECTION 80 0.0069
352 VITAMIN D DEFICIENCY 67 0.0069
353 SKIN FISSURES 134 0.0068
354 DRUG INTOLERANCE 662 0.0068
355 CATARACT 408 0.0068
356 DECREASED APPETITE 1591 0.0068
357 ABDOMINAL DISCOMFORT 1149 0.0068
358 HAEMOPTYSIS 191 0.0068
359 LEUKOCYTOSIS 123 0.0068
360 PRODUCT TASTE ABNORMAL 92 0.0068
361 HYPONATRAEMIA 382 0.0068
362 BRADYCARDIA 359 0.0068
363 GLAUCOMA 130 0.0067
364 SUICIDE ATTEMPT 409 0.0067
365 BLOOD TRIGLYCERIDES INCREASED 119 0.0067
366 HYPERVENTILATION 39 0.0067
367 HYPERCALCAEMIA 83 0.0067
368 COMA 320 0.0067
369 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 478 0.0067
370 FEELING COLD 187 0.0067
371 HYPOXIA 236 0.0067
372 HYPERTHYROIDISM 97 0.0067
373 GASTROINTESTINAL INFECTION 60 0.0067
374 OCULAR DISCOMFORT 75 0.0067
375 OXYGEN SATURATION DECREASED 375 0.0067
376 ISCHAEMIC STROKE 119 0.0067
377 BRONCHITIS 492 0.0066
378 CIRCULATORY COLLAPSE 113 0.0066
379 HYPOAESTHESIA ORAL 100 0.0066
380 BASAL CELL CARCINOMA 103 0.0066
381 DYSURIA 243 0.0066
382 PREMATURE DELIVERY 105 0.0066
383 FOOT DEFORMITY 73 0.0066
384 PRODUCT DISTRIBUTION ISSUE 61 0.0066
385 NEPHROLITHIASIS 301 0.0066
386 MUSCULOSKELETAL PAIN 343 0.0065
387 LOW BIRTH WEIGHT BABY 52 0.0065
388 WALKING AID USER 43 0.0065
389 EOSINOPHILIA 114 0.0065
390 MOBILITY DECREASED 466 0.0065
391 HEPATITIS ACUTE 42 0.0065
392 BLOOD UREA INCREASED 108 0.0064
393 WEIGHT FLUCTUATION 67 0.0064
394 EJECTION FRACTION DECREASED 99 0.0064
395 NODULE 83 0.0064
396 DRY MOUTH 516 0.0064
397 PERIPHERAL SWELLING 977 0.0063
398 LOCALISED INFECTION 153 0.0063
399 ABDOMINAL DISTENSION 656 0.0063
400 CARDIAC FAILURE 504 0.0063
401 MELAENA 138 0.0063
402 ANKLE FRACTURE 97 0.0063
403 RHINORRHOEA 404 0.0062
404 HAEMATURIA 214 0.0062
405 CARDIAC ARREST 514 0.0062
406 CARDIOMYOPATHY 92 0.0062
407 DYSPEPSIA 611 0.0062
408 FAECES SOFT 45 0.0062
409 PULMONARY MASS 92 0.0062
410 ILLNESS 636 0.0062
411 TRICUSPID VALVE INCOMPETENCE 49 0.0062
412 SLEEP DISORDER 435 0.0062
413 POLLAKIURIA 257 0.0062
414 ABNORMAL LOSS OF WEIGHT 42 0.0062
415 HAEMATOCRIT DECREASED 122 0.0061
416 URINARY INCONTINENCE 182 0.0061
417 OEDEMA 333 0.0061
418 CHOLANGITIS 38 0.0061
419 CARDIAC MURMUR 53 0.0061
420 THIRST 109 0.0061
421 DUODENAL ULCER 43 0.0061
422 HYPERTENSION 1288 0.0061
423 COUGH 1696 0.0060
424 MUSCULOSKELETAL CHEST PAIN 93 0.0060
425 SINUSITIS 615 0.0060
426 ANGINA UNSTABLE 39 0.0060
427 FALL 1988 0.0060
428 HEPATIC ENZYME INCREASED 407 0.0060
429 IRON DEFICIENCY ANAEMIA 55 0.0060
430 DIVERTICULITIS 165 0.0059
431 CORONARY ARTERY DISEASE 180 0.0059
432 NECK PAIN 332 0.0059
433 WRONG PRODUCT ADMINISTERED 40 0.0059
434 CELLULITIS 298 0.0059
435 DECUBITUS ULCER 48 0.0059
436 SNEEZING 132 0.0059
437 BLOOD PRESSURE ABNORMAL 117 0.0059
438 ACUTE RESPIRATORY FAILURE 113 0.0059
439 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130 0.0059
440 TOXIC SKIN ERUPTION 59 0.0059
441 VOMITING 2749 0.0058
442 HYPERTENSIVE CRISIS 65 0.0058
443 PULMONARY CONGESTION 77 0.0058
444 PRESYNCOPE 142 0.0058
445 WEIGHT DECREASED 1628 0.0058
446 SYNCOPE 583 0.0058
447 BRADYPHRENIA 38 0.0058
448 ASTHENIA 2184 0.0058
449 BLOOD PRESSURE INCREASED 886 0.0058
450 FOETAL EXPOSURE DURING PREGNANCY 470 0.0058
451 CEREBRAL INFARCTION 141 0.0058
452 INFUSION RELATED REACTION 380 0.0057
453 BLOOD SODIUM DECREASED 108 0.0057
454 DIALYSIS 81 0.0057
455 STOMATITIS 345 0.0057
456 INTENTIONAL PRODUCT USE ISSUE 496 0.0057
457 BALANCE DISORDER 487 0.0056
458 ACCIDENTAL OVERDOSE 206 0.0056
459 SEPTIC SHOCK 244 0.0056
460 VENTRICULAR FIBRILLATION 62 0.0056
461 SPINAL OSTEOARTHRITIS 49 0.0056
462 EAR INFECTION 148 0.0056
463 BRAIN FOG 87 0.0055
464 RED BLOOD CELL COUNT DECREASED 158 0.0055
465 CHOLESTASIS 106 0.0055
466 ORTHOSTATIC HYPOTENSION 96 0.0055
467 NASOPHARYNGITIS 1016 0.0055
468 UNRESPONSIVE TO STIMULI 142 0.0055
469 HEAD INJURY 174 0.0055
470 CARPAL TUNNEL SYNDROME 77 0.0055
471 BRAIN INJURY 55 0.0055
472 PNEUMONIA ASPIRATION 137 0.0055
473 NEOPLASM 63 0.0055
474 INFLUENZA 609 0.0055
475 INITIAL INSOMNIA 56 0.0055
476 BLOOD POTASSIUM DECREASED 164 0.0054
477 RESTLESS LEGS SYNDROME 99 0.0054
478 SMALL INTESTINAL OBSTRUCTION 67 0.0054
479 PAROSMIA 41 0.0054
480 FOOT FRACTURE 103 0.0054
481 CHEST DISCOMFORT 556 0.0054
482 PRESCRIBED OVERDOSE 105 0.0054
483 BLOOD PRESSURE DECREASED 360 0.0054
484 JOINT SWELLING 654 0.0054
485 GOUT 97 0.0054
486 GENERAL PHYSICAL HEALTH DETERIORATION 624 0.0054
487 URINARY TRACT INFECTION 919 0.0054
488 ASPIRATION 59 0.0054
489 CHOKING 105 0.0054
490 SKIN ULCER 139 0.0054
491 MIDDLE INSOMNIA 100 0.0053
492 AUTOIMMUNE DISORDER 52 0.0053
493 SWELLING 494 0.0053
494 GASTROENTERITIS VIRAL 95 0.0053
495 FLATULENCE 298 0.0052
496 CHRONIC KIDNEY DISEASE 398 0.0052
497 HERNIA 101 0.0052
498 BLOOD THYROID STIMULATING HORMONE INCREASED 48 0.0052
499 BLOOD CREATINE PHOSPHOKINASE INCREASED 150 0.0052
500 OROPHARYNGEAL DISCOMFORT 47 0.0052
501 ACUTE RESPIRATORY DISTRESS SYNDROME 92 0.0052
502 ABDOMINAL PAIN 1207 0.0052
503 WHITE BLOOD CELL COUNT INCREASED 199 0.0052
504 COVID-19 909 0.0052
505 MIGRAINE 494 0.0052
506 SINUS BRADYCARDIA 50 0.0052
507 AGEUSIA 129 0.0052
508 POISONING DELIBERATE 49 0.0052
509 DELIRIUM 179 0.0052
510 RESPIRATORY DISORDER 154 0.0051
511 ATRIAL FIBRILLATION 501 0.0051
512 CARDIO-RESPIRATORY ARREST 215 0.0051
513 NEURALGIA 125 0.0051
514 PULMONARY HYPERTENSION 107 0.0051
515 DEPRESSED MOOD 271 0.0051
516 SCRATCH 54 0.0051
517 MUSCULOSKELETAL STIFFNESS 448 0.0051
518 PHARYNGEAL SWELLING 50 0.0051
519 GASTRIC ULCER 97 0.0051
520 TRANSIENT ISCHAEMIC ATTACK 172 0.0051
521 BODY TEMPERATURE INCREASED 104 0.0051
522 BOWEL MOVEMENT IRREGULARITY 39 0.0051
523 LYMPHOCYTE COUNT DECREASED 90 0.0051
524 MUSCLE SPASMS 933 0.0051
525 TOOTH INFECTION 67 0.0051
526 RETCHING 108 0.0051
527 COLD SWEAT 89 0.0050
528 FLUID RETENTION 256 0.0050
529 MENTAL STATUS CHANGES 139 0.0050
530 MEMORY IMPAIRMENT 686 0.0050
531 PREMATURE BABY 150 0.0050
532 UPPER-AIRWAY COUGH SYNDROME 41 0.0050
533 OROPHARYNGEAL PAIN 460 0.0050
534 RHEUMATOID ARTHRITIS 564 0.0050
535 CARDIOMEGALY 61 0.0050
536 ILL-DEFINED DISORDER 301 0.0049
537 RESPIRATORY TRACT INFECTION 129 0.0049
538 SECRETION DISCHARGE 62 0.0049
539 ARTHRITIS 387 0.0049
540 ABDOMINAL PAIN UPPER 1012 0.0049
541 CANDIDA INFECTION 83 0.0049
542 PARAESTHESIA 773 0.0049
543 LIMB DISCOMFORT 152 0.0049
544 INTENTIONAL DOSE OMISSION 140 0.0049
545 RESPIRATORY FAILURE 358 0.0049
546 NASAL CONGESTION 288 0.0049
547 ATRIAL SEPTAL DEFECT 41 0.0049
548 PHOTOPHOBIA 92 0.0049
549 MOVEMENT DISORDER 157 0.0049
550 BLOOD PRESSURE FLUCTUATION 117 0.0049
551 ADRENAL INSUFFICIENCY 59 0.0049
552 BLOOD LACTATE DEHYDROGENASE INCREASED 77 0.0049
553 DRUG EFFECT LESS THAN EXPECTED 72 0.0049
554 POISONING 61 0.0049
555 PRODUCT ADMINISTRATION ERROR 98 0.0048
556 HYPERSOMNIA 139 0.0048
557 DYSPNOEA 2734 0.0048
558 PAIN IN EXTREMITY 1422 0.0048
559 TENDERNESS 50 0.0048
560 OSTEOPOROSIS 197 0.0048
561 VENTRICULAR TACHYCARDIA 79 0.0048
562 HALLUCINATION, VISUAL 101 0.0048
563 GINGIVAL PAIN 38 0.0048
564 SKIN REACTION 67 0.0048
565 LIGAMENT SPRAIN 47 0.0047
566 SKIN EXFOLIATION 401 0.0047
567 AGRANULOCYTOSIS 88 0.0047
568 LACRIMATION INCREASED 143 0.0047
569 LOSS OF CONSCIOUSNESS 606 0.0047
570 INTERSTITIAL LUNG DISEASE 229 0.0047
571 INTERNAL HAEMORRHAGE 54 0.0047
572 ANAEMIA 901 0.0047
573 OEDEMA PERIPHERAL 574 0.0047
574 PNEUMONIA 1522 0.0047
575 LETHARGY 270 0.0047
576 PHARYNGITIS 58 0.0047
577 CORONARY ARTERY OCCLUSION 64 0.0047
578 NAUSEA 3682 0.0046
579 LIVER DISORDER 206 0.0046
580 CHEST PAIN 860 0.0046
581 FEEDING DISORDER 94 0.0046
582 FREQUENT BOWEL MOVEMENTS 125 0.0046
583 HYPERHIDROSIS 595 0.0046
584 METASTASES TO LIVER 81 0.0046
585 SCHIZOPHRENIA 56 0.0046
586 MUSCLE RIGIDITY 55 0.0046
587 ANAPHYLACTIC REACTION 254 0.0046
588 CONSTIPATION 1002 0.0046
589 WRIST FRACTURE 55 0.0046
590 FLUSHING 466 0.0046
591 PRODUCT DOSE OMISSION ISSUE 1346 0.0046
592 NEUROPATHY PERIPHERAL 435 0.0046
593 RESPIRATORY DISTRESS 126 0.0046
594 GASTRITIS 120 0.0046
595 SCAB 52 0.0046
596 HEART RATE DECREASED 160 0.0046
597 HEART RATE INCREASED 451 0.0045
598 HAEMOGLOBIN DECREASED 467 0.0045
599 SKIN INFECTION 51 0.0045
600 WEIGHT INCREASED 1018 0.0045
601 SPEECH DISORDER 238 0.0045
602 HAEMATEMESIS 115 0.0045
603 PRODUCT PRESCRIBING ERROR 108 0.0045
604 HALLUCINATION, AUDITORY 72 0.0045
605 PURPURA 40 0.0045
606 FAECES DISCOLOURED 98 0.0045
607 ERECTILE DYSFUNCTION 116 0.0045
608 HOT FLUSH 340 0.0045
609 POLYNEUROPATHY 54 0.0045
610 MUSCLE ATROPHY 57 0.0045
611 DIZZINESS 2243 0.0045
612 TREATMENT NONCOMPLIANCE 246 0.0045
613 INJURY 316 0.0045
614 HYPOAESTHESIA 672 0.0045
615 DEPRESSED LEVEL OF CONSCIOUSNESS 177 0.0045
616 PRESCRIBED UNDERDOSE 89 0.0045
617 INJECTION SITE NODULE 49 0.0044
618 CARDIOVASCULAR DISORDER 113 0.0044
619 DECREASED ACTIVITY 48 0.0044
620 SUDDEN DEATH 47 0.0044
621 DELUSION 69 0.0044
622 THERAPY NON-RESPONDER 199 0.0044
623 PULMONARY OEDEMA 198 0.0044
624 EYE HAEMORRHAGE 59 0.0044
625 DYSSTASIA 129 0.0044
626 HIATUS HERNIA 57 0.0044
627 ERYTHEMA MULTIFORME 41 0.0044
628 BODY HEIGHT DECREASED 47 0.0044
629 OESOPHAGITIS 48 0.0044
630 ACUTE HEPATIC FAILURE 60 0.0044
631 DEPRESSION 998 0.0044
632 PRODUCT USE COMPLAINT 69 0.0044
633 HUNGER 61 0.0044
634 METASTASES TO LUNG 50 0.0043
635 TENDONITIS 67 0.0043
636 DISCOMFORT 264 0.0043
637 SARS-COV-2 TEST POSITIVE 57 0.0043
638 INTERNATIONAL NORMALISED RATIO INCREASED 123 0.0043
639 RENAL DISORDER 201 0.0043
640 THROAT IRRITATION 193 0.0043
641 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 38 0.0043
642 EUPHORIC MOOD 44 0.0043
643 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224 0.0043
644 BACTERIAL INFECTION 80 0.0043
645 URINARY RETENTION 143 0.0043
646 ROTATOR CUFF SYNDROME 55 0.0043
647 TOXIC EPIDERMAL NECROLYSIS 65 0.0043
648 DIARRHOEA HAEMORRHAGIC 40 0.0043
649 KNEE OPERATION 42 0.0043
650 MALAISE 1862 0.0042
651 BACK DISORDER 69 0.0042
652 CYTOKINE RELEASE SYNDROME 85 0.0042
653 VENTRICULAR EXTRASYSTOLES 44 0.0042
654 CONDITION AGGRAVATED 1287 0.0042
655 FUNGAL INFECTION 141 0.0042
656 FEELING HOT 259 0.0042
657 MEDICATION ERROR 234 0.0042
658 INTERVERTEBRAL DISC PROTRUSION 92 0.0042
659 HEPATIC FUNCTION ABNORMAL 157 0.0042
660 HAEMORRHOIDS 82 0.0042
661 MALNUTRITION 47 0.0042
662 TACHYCARDIA 373 0.0042
663 GAIT DISTURBANCE 803 0.0042
664 FATIGUE 3261 0.0042
665 PRURITUS 1601 0.0042
666 THROMBOSIS 335 0.0042
667 INCONTINENCE 44 0.0042
668 BACK PAIN 967 0.0042
669 SKIN LESION 114 0.0042
670 PROTEINURIA 79 0.0042
671 ALANINE AMINOTRANSFERASE INCREASED 255 0.0041
672 MYALGIA 705 0.0041
673 ARTHRALGIA 1721 0.0041
674 NERVE INJURY 46 0.0041
675 POOR QUALITY SLEEP 89 0.0041
676 RIB FRACTURE 85 0.0041
677 NEUROLEPTIC MALIGNANT SYNDROME 49 0.0041
678 KIDNEY INFECTION 81 0.0041
679 MUSCULOSKELETAL DISCOMFORT 71 0.0041
680 TOOTH ABSCESS 42 0.0041
681 SEPSIS 460 0.0041
682 DRUG ERUPTION 73 0.0041
683 LOWER LIMB FRACTURE 79 0.0041
684 HAEMATOMA 106 0.0041
685 VERTIGO 249 0.0041
686 ASPARTATE AMINOTRANSFERASE INCREASED 217 0.0041
687 THYROID CANCER 49 0.0041
688 VITREOUS FLOATERS 40 0.0041
689 SPINAL OPERATION 50 0.0041
690 CONTUSION 390 0.0040
691 MULTI-ORGAN FAILURE 70 0.0040
692 RASH MACULO-PAPULAR 90 0.0040
693 EYE DISORDER 133 0.0040
694 ADVERSE DRUG REACTION 363 0.0040
695 GENERALISED OEDEMA 50 0.0040
696 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 727 0.0040
697 ERUCTATION 78 0.0040
698 ORAL CANDIDIASIS 53 0.0040
699 IMPAIRED WORK ABILITY 86 0.0040
700 PALPITATIONS 471 0.0040
701 EYE SWELLING 149 0.0040
702 DIPLOPIA 104 0.0040
703 DYSPHONIA 234 0.0040
704 CARDIAC FAILURE CONGESTIVE 320 0.0040
705 OVERDOSE 857 0.0040
706 PRODUCT USE IN UNAPPROVED INDICATION 984 0.0040
707 HEPATOMEGALY 39 0.0040
708 INFLUENZA LIKE ILLNESS 326 0.0040
709 TRANSAMINASES INCREASED 88 0.0040
710 SOMNOLENCE 796 0.0039
711 HEPATIC FAILURE 119 0.0039
712 CHOLECYSTECTOMY 45 0.0039
713 RECTAL HAEMORRHAGE 169 0.0039
714 PERIPHERAL COLDNESS 54 0.0039
715 PULMONARY EMBOLISM 373 0.0039
716 PANIC ATTACK 143 0.0039
717 ELECTROCARDIOGRAM QT PROLONGED 141 0.0039
718 CEREBROVASCULAR ACCIDENT 662 0.0039
719 ARRHYTHMIA 185 0.0039
720 DISSEMINATED INTRAVASCULAR COAGULATION 55 0.0039
721 RENAL INJURY 116 0.0039
722 PRODUCT DISPENSING ERROR 85 0.0039
723 END STAGE RENAL DISEASE 71 0.0039
724 CEREBRAL HAEMORRHAGE 139 0.0039
725 EYE PRURITUS 130 0.0039
726 HEADACHE 2425 0.0039
727 RENAL PAIN 41 0.0039
728 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 66 0.0038
729 PANCYTOPENIA 215 0.0038
730 GASTRIC HAEMORRHAGE 44 0.0038
731 EPISTAXIS 286 0.0038
732 FULL BLOOD COUNT DECREASED 77 0.0038
733 HEREDITARY ANGIOEDEMA 41 0.0038
734 PHOTOSENSITIVITY REACTION 63 0.0038
735 GINGIVAL BLEEDING 52 0.0038
736 DRY EYE 190 0.0038
737 HERPES ZOSTER 218 0.0038
738 URTICARIA 632 0.0038
739 HEART RATE IRREGULAR 85 0.0038
740 COLON CANCER 56 0.0038
741 VIRAL INFECTION 125 0.0038
742 TOOTHACHE 68 0.0038
743 SKIN DISORDER 125 0.0037
744 BLOOD ALKALINE PHOSPHATASE INCREASED 93 0.0037
745 ECZEMA 195 0.0037
746 TREATMENT FAILURE 308 0.0037
747 CARDIAC DISORDER 347 0.0037
748 RESTLESSNESS 135 0.0037
749 DISORIENTATION 146 0.0037
750 DRY SKIN 490 0.0037
751 VISION BLURRED 504 0.0037
752 BURNING SENSATION 257 0.0037
753 INCREASED APPETITE 70 0.0037
754 INSOMNIA 971 0.0036
755 GASTRIC DISORDER 125 0.0036
756 BLINDNESS 148 0.0036
757 EYE INFECTION 41 0.0036
758 UPPER GASTROINTESTINAL HAEMORRHAGE 61 0.0036
759 ANGIOEDEMA 160 0.0036
760 HYPOACUSIS 155 0.0036
761 DYSPHAGIA 341 0.0036
762 ANOSMIA 52 0.0036
763 CHILLS 421 0.0036
764 PERICARDIAL EFFUSION 83 0.0036
765 OSTEOMYELITIS 65 0.0036
766 SPINAL PAIN 42 0.0036
767 NEUTROPHIL COUNT DECREASED 146 0.0036
768 NEEDLE ISSUE 104 0.0036
769 KNEE ARTHROPLASTY 75 0.0036
770 OCULAR HYPERAEMIA 169 0.0036
771 BLOOD TEST ABNORMAL 50 0.0036
772 SURGERY 208 0.0035
773 GASTROINTESTINAL PAIN 39 0.0035
774 DISABILITY 70 0.0035
775 PNEUMOTHORAX 56 0.0035
776 GALLBLADDER DISORDER 63 0.0035
777 THERAPY INTERRUPTED 252 0.0035
778 PAIN 2163 0.0035
779 HYPERSENSITIVITY 653 0.0035
780 DYSGEUSIA 261 0.0035
781 PRODUCT SUBSTITUTION ISSUE 202 0.0035
782 JAUNDICE 94 0.0035
783 SKIN DISCOLOURATION 160 0.0035
784 COAGULOPATHY 58 0.0035
785 ABDOMINAL PAIN LOWER 88 0.0035
786 METASTASES TO BONE 57 0.0035
787 DEMENTIA 97 0.0035
788 INCORRECT PRODUCT ADMINISTRATION DURATION 75 0.0035
789 PROCEDURAL PAIN 96 0.0035
790 ILEUS 43 0.0035
791 PAIN IN JAW 98 0.0035
792 PYREXIA 1197 0.0035
793 ULCER 55 0.0035
794 PULMONARY ARTERIAL HYPERTENSION 50 0.0034
795 RESPIRATORY ARREST 95 0.0034
796 RASH PRURITIC 184 0.0034
797 INFECTION 491 0.0034
798 ANXIETY 964 0.0034
799 PLATELET COUNT DECREASED 361 0.0034
800 BLOOD COUNT ABNORMAL 51 0.0034
801 SWOLLEN TONGUE 105 0.0034
802 IMMUNODEFICIENCY 50 0.0034
803 COLITIS 127 0.0033
804 DISTURBANCE IN ATTENTION 180 0.0033
805 AMNESIA 217 0.0033
806 THERAPY PARTIAL RESPONDER 52 0.0033
807 PLEURAL EFFUSION 202 0.0033
808 MYOCARDIAL INFARCTION 577 0.0033
809 THERAPEUTIC RESPONSE DECREASED 200 0.0033
810 BACTERAEMIA 39 0.0033
811 ORAL HERPES 64 0.0033
812 COGNITIVE DISORDER 153 0.0033
813 HEAD DISCOMFORT 58 0.0033
814 TREMOR 543 0.0033
815 ASCITES 96 0.0033
816 PRODUCT AVAILABILITY ISSUE 74 0.0032
817 UNDERDOSE 237 0.0032
818 THYROID DISORDER 50 0.0032
819 HEPATOTOXICITY 72 0.0032
820 PRODUCT USE ISSUE 606 0.0032
821 DERMATITIS ATOPIC 170 0.0032
822 PLATELET COUNT INCREASED 42 0.0032
823 MENTAL IMPAIRMENT 78 0.0032
824 ORAL PAIN 72 0.0032
825 SUBDURAL HAEMATOMA 46 0.0032
826 JOINT STIFFNESS 84 0.0032
827 HIP ARTHROPLASTY 49 0.0032
828 PALLOR 87 0.0032
829 PROSTATIC SPECIFIC ANTIGEN INCREASED 44 0.0032
830 ROAD TRAFFIC ACCIDENT 133 0.0032
831 ALOPECIA 624 0.0032
832 RASH 1385 0.0032
833 VISUAL IMPAIRMENT 390 0.0031
834 WHITE BLOOD CELL COUNT DECREASED 341 0.0031
835 INTENTIONAL PRODUCT MISUSE 274 0.0031
836 EYE IRRITATION 180 0.0031
837 INJECTION SITE DISCOLOURATION 39 0.0031
838 PANCREATIC CARCINOMA 90 0.0031
839 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 80 0.0031
840 THERAPEUTIC RESPONSE SHORTENED 103 0.0031
841 CYST 38 0.0031
842 IMPAIRED QUALITY OF LIFE 44 0.0031
843 PSORIASIS 398 0.0030
844 RASH ERYTHEMATOUS 145 0.0030
845 GENERALISED TONIC-CLONIC SEIZURE 50 0.0030
846 MENTAL DISORDER 131 0.0030
847 THROMBOCYTOPENIA 336 0.0030
848 LYMPHADENOPATHY 106 0.0030
849 LIVER FUNCTION TEST ABNORMAL 87 0.0030
850 HAEMATOCHEZIA 165 0.0030
851 ADVERSE EVENT 274 0.0030
852 INTENTIONAL SELF-INJURY 60 0.0030
853 ORAL DISCOMFORT 41 0.0029
854 INJECTION SITE REACTION 203 0.0029
855 NERVOUSNESS 154 0.0029
856 PSYCHOTIC DISORDER 87 0.0029
857 VISUAL ACUITY REDUCED 97 0.0029
858 MUSCLE TIGHTNESS 47 0.0029
859 RASH MACULAR 101 0.0029
860 FEELING ABNORMAL 692 0.0029
861 ERYTHEMA 593 0.0029
862 CHROMATURIA 65 0.0029
863 GASTROINTESTINAL HAEMORRHAGE 240 0.0029
864 INJECTION SITE MASS 106 0.0029
865 HALLUCINATION 216 0.0029
866 PARAESTHESIA ORAL 41 0.0028
867 LYMPHOPENIA 40 0.0028
868 CYANOSIS 44 0.0028
869 LABORATORY TEST ABNORMAL 82 0.0028
870 NEUTROPENIA 374 0.0027
871 AGITATION 202 0.0027
872 MUCOSAL INFLAMMATION 72 0.0027
873 SCAR 47 0.0027
874 EXPOSURE VIA SKIN CONTACT 71 0.0027
875 PRURITUS GENERALISED 59 0.0027
876 PARALYSIS 39 0.0027
877 APHONIA 38 0.0027
878 BLOOD BILIRUBIN INCREASED 73 0.0027
879 INTESTINAL OBSTRUCTION 101 0.0027
880 DERMATITIS 56 0.0027
881 THROAT TIGHTNESS 72 0.0027
882 HIP FRACTURE 85 0.0026
883 MOOD ALTERED 72 0.0026
884 ANAPHYLACTIC SHOCK 68 0.0026
885 OFF LABEL USE 2297 0.0026
886 TOOTH DISORDER 58 0.0026
887 DYSKINESIA 106 0.0026
888 BONE PAIN 151 0.0026
889 ECONOMIC PROBLEM 39 0.0026
890 DEEP VEIN THROMBOSIS 164 0.0025
891 FEBRILE NEUTROPENIA 167 0.0025
892 SWELLING FACE 160 0.0025
893 POST PROCEDURAL COMPLICATION 47 0.0024
894 ABSCESS 39 0.0024
895 NERVOUS SYSTEM DISORDER 76 0.0024
896 SENSORY DISTURBANCE 39 0.0024
897 PRODUCT QUALITY ISSUE 330 0.0024
898 PNEUMONITIS 66 0.0024
899 BONE DISORDER 44 0.0024
900 PREGNANCY 48 0.0024
901 TINNITUS 110 0.0024
902 FACE OEDEMA 40 0.0024
903 DEAFNESS 62 0.0024
904 MANIA 39 0.0024
905 STAPHYLOCOCCAL INFECTION 78 0.0024
906 MUSCULOSKELETAL DISORDER 45 0.0024
907 HAEMORRHAGE 247 0.0024
908 PRODUCT PRESCRIBING ISSUE 51 0.0023
909 NEOPLASM MALIGNANT 155 0.0023
910 SEIZURE 267 0.0023
911 ANGER 78 0.0023
912 EXTRAPYRAMIDAL DISORDER 57 0.0023
913 PRODUCT PHYSICAL ISSUE 46 0.0023
914 HOSPITALISATION 350 0.0023
915 INJECTION SITE PAIN 695 0.0023
916 PARANOIA 39 0.0023
917 THERAPEUTIC RESPONSE UNEXPECTED 101 0.0022
918 DEVICE USE ISSUE 39 0.0022
919 FEMUR FRACTURE 69 0.0022
920 CONJUNCTIVITIS 41 0.0022
921 UPPER LIMB FRACTURE 44 0.0022
922 DRUG INEFFECTIVE 2895 0.0022
923 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51 0.0022
924 SKIN CANCER 47 0.0022
925 INCORRECT DOSE ADMINISTERED 493 0.0022
926 ABORTION SPONTANEOUS 86 0.0021
927 LEUKOPENIA 107 0.0021
928 DRUG ABUSE 178 0.0021
929 NIGHTMARE 70 0.0020
930 SUICIDAL IDEATION 184 0.0020
931 FEELING JITTERY 38 0.0020
932 INJECTION SITE SWELLING 151 0.0020
933 FEAR 53 0.0020
934 ABNORMAL BEHAVIOUR 78 0.0020
935 CRYING 71 0.0020
936 SPINAL FRACTURE 39 0.0019
937 INJECTION SITE PRURITUS 130 0.0019
938 MALIGNANT NEOPLASM PROGRESSION 198 0.0019
939 PAIN OF SKIN 52 0.0019
940 INJECTION SITE BRUISING 153 0.0019
941 BLADDER CANCER 112 0.0019
942 RASH GENERALISED 49 0.0019
943 UNEVALUABLE EVENT 143 0.0019
944 MULTIPLE SCLEROSIS 90 0.0019
945 EXPIRED PRODUCT ADMINISTERED 61 0.0018
946 ANHEDONIA 47 0.0018
947 IRRITABILITY 107 0.0018
948 DISEASE PROGRESSION 210 0.0018
949 ABNORMAL DREAMS 49 0.0018
950 LIP SWELLING 59 0.0018
951 LUNG NEOPLASM MALIGNANT 71 0.0017
952 INJECTION SITE HAEMORRHAGE 137 0.0017
953 AGGRESSION 85 0.0017
954 INJECTION SITE ERYTHEMA 207 0.0017
955 NEOPLASM PROGRESSION 58 0.0017
956 MULTIPLE SCLEROSIS RELAPSE 114 0.0017
957 SKIN BURNING SENSATION 117 0.0016
958 COLITIS ULCERATIVE 72 0.0016
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 325 0.0016
960 MOOD SWINGS 50 0.0016
961 DISEASE RECURRENCE 73 0.0015
962 EXTRA DOSE ADMINISTERED 62 0.0015
963 THERAPY CESSATION 77 0.0015
964 INJECTION SITE RASH 46 0.0015
965 DRUG ADMINISTRATION ERROR 45 0.0015
966 DEATH 1258 0.0015
967 EMOTIONAL DISORDER 44 0.0014
968 OSTEONECROSIS 43 0.0013
969 DEVICE DISLOCATION 55 0.0013
970 ACCIDENTAL EXPOSURE TO PRODUCT 130 0.0013
971 PROSTATE CANCER 101 0.0013
972 DEVICE LEAKAGE 54 0.0012
973 DEVICE MALFUNCTION 87 0.0012
974 DEVICE ISSUE 111 0.0012
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 56 0.0012
976 DRUG DOSE OMISSION 197 0.0012
977 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 65 0.0012
978 EMOTIONAL DISTRESS 143 0.0012
979 PRODUCT STORAGE ERROR 102 0.0012
980 VAGINAL HAEMORRHAGE 50 0.0012
981 BREAST CANCER 107 0.0011
982 WITHDRAWAL SYNDROME 48 0.0011
983 MYELOSUPPRESSION 41 0.0011
984 PLASMA CELL MYELOMA 44 0.0011
985 NO ADVERSE EVENT 202 0.0011
986 PRODUCT DOSE OMISSION 69 0.0011
987 SKIN IRRITATION 45 0.0010
988 CONVULSION 55 0.0010
989 ACNE 72 0.0009
990 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 63 0.0009
991 RENAL CANCER 40 0.0008
992 DRUG EFFECT DECREASED 39 0.0007
993 DRUG DEPENDENCE 95 0.0006